Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Immunity mutation discovered in zoonotic bacteria
The study investigated the response of Staphylococcus aureus to macrophages.
The mutation helps the bacteria survive immune responses and antibiotics.

New research has discovered a genetic mutation, which is helping zoonotic bacteria to develop a resistance to immune system defences and antibiotics.

Researchers from the Roslin Institute studied the response of Staphylococcus aureus, a major pathogen affecting both humans and animals, to immune cells known as macrophages.

The study aimed to discover how the bacteria was avoiding being killed by macrophages, and how it was adapting to immune responses.

Macrophages represent a significant component in the immune system response to S.aureus, and play a major part in disease outcomes. The researchers passaged strains of S.aureus along a macrophage cell line, where it collected mutations.

Exposure to the macrophages saw the bacteria undergo changes to its characteristics over time. Mutations meant that the bacteria developed many of its survival traits, including an ability to grow within immune cells and resist antibiotics.

However these advantages proved to be conditional, with the bacteria losing these mutations when grown in nutrient-rich conditions away from macrophages.

Further research revealed that the phenotype which was contributing to bacterial survival was a new type of small colony variant (SCV). These variants frequently contribute to more persistent, but less virulent, form of the pathogen.

These SCVs are often linked to chronic infections such as osteomyelitis and lung infections in cystic fibrosis patients. The adaptation has also led to the bacteria becoming more resistant to antibiotics, such as vancomycin.

The new model suggests that repeatedly exposing bacteria to macrophages could reveal the conditional way that bacteria adapts to specific niches.

It may also lead to a better understanding of how bacteria can evade the immune system, meaning scientists can consider potential treatment strategies for both humans and animals.

Dr Joana Alves, a research fellow at the Roslin Institute, said: “Our study uncovers a novel adaptation strategy by S. aureus in response to immune challenges, highlighting the remarkable ingenuity of pathogens in evading host defences.

“Our findings demonstrate the power of experimental models to unravel the complex mechanisms underlying bacterial adaptation during infection”

The full study can be found in the journal mBio.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.